Experiment: 6HQ1

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D 1H-15N NOESY	0.925 mM [U-99% 13C; U-99% 15N] H1-GD, 10 mM Tris, 157 mM KCl, 0.1 mM EDTA, 0.125 mM DSS	90% H2O/10% D2O	165 mM	7.4	1 atm	283	Varian INOVA 800
2	2D 1H-15N HSQC	0.25 mM [U-99% 13C; U-99% 15N] H1-GD, 10 mM Tris, 157 mM KCl, 0.1 mM EDTA, 0.125 mM DSS	90% H2O/10% D2O	165 mM	7.4	1 atm	283	Varian INOVA 800
3	3D HNCO	0.25 mM [U-99% 13C; U-99% 15N] H1-GD, 10 mM Tris, 157 mM KCl, 0.1 mM EDTA, 0.125 mM DSS	90% H2O/10% D2O	165 mM	7.4	1 atm	283	Varian INOVA 800
4	3D HNCACB	0.25 mM [U-99% 13C; U-99% 15N] H1-GD, 10 mM Tris, 157 mM KCl, 0.1 mM EDTA, 0.125 mM DSS	90% H2O/10% D2O	165 mM	7.4	1 atm	283	Varian INOVA 800
5	3D HN(CO)CA	0.25 mM [U-99% 13C; U-99% 15N] H1-GD, 10 mM Tris, 157 mM KCl, 0.1 mM EDTA, 0.125 mM DSS	90% H2O/10% D2O	165 mM	7.4	1 atm	283	Varian INOVA 800
6	3D CBCA(CO)NH	0.25 mM [U-99% 13C; U-99% 15N] H1-GD, 10 mM Tris, 157 mM KCl, 0.1 mM EDTA, 0.125 mM DSS	90% H2O/10% D2O	165 mM	7.4	1 atm	283	Varian INOVA 800
7	3D HNCA	0.25 mM [U-99% 13C; U-99% 15N] H1-GD, 10 mM Tris, 157 mM KCl, 0.1 mM EDTA, 0.125 mM DSS	90% H2O/10% D2O	165 mM	7.4	1 atm	283	Varian INOVA 800
8	2D 1H-15N HSQC	0.925 mM [U-99% 13C; U-99% 15N] H1-GD, 10 mM Tris, 157 mM KCl, 0.1 mM EDTA, 0.125 mM DSS	90% H2O/10% D2O	165 mM	7.4	1 atm	283	Bruker AVANCE III 750
9	3D HNCACB	0.925 mM [U-99% 13C; U-99% 15N] H1-GD, 10 mM Tris, 157 mM KCl, 0.1 mM EDTA, 0.125 mM DSS	90% H2O/10% D2O	165 mM	7.4	1 atm	283	Bruker AVANCE III 750
10	3D 1H-13C NOESY aliphatic	0.925 mM [U-99% 13C; U-99% 15N] H1-GD, 10 mM Tris, 157 mM KCl, 0.1 mM EDTA, 0.125 mM DSS	90% H2O/10% D2O	165 mM	7.4	1 atm	283	Bruker AVANCE III 750
11	3D 1H-13C NOESY aromatic	0.925 mM [U-99% 13C; U-99% 15N] H1-GD, 10 mM Tris, 157 mM KCl, 0.1 mM EDTA, 0.125 mM DSS	90% H2O/10% D2O	165 mM	7.4	1 atm	283	Bruker AVANCE III 750
12	3D HCCH-TOCSY	0.925 mM [U-99% 13C; U-99% 15N] H1-GD, 10 mM Tris, 157 mM KCl, 0.1 mM EDTA, 0.125 mM DSS	90% H2O/10% D2O	165 mM	7.4	1 atm	283	Varian INOVA 800
13	3D 1H-15N TOCSY	0.925 mM [U-99% 13C; U-99% 15N] H1-GD, 10 mM Tris, 157 mM KCl, 0.1 mM EDTA, 0.125 mM DSS	90% H2O/10% D2O	165 mM	7.4	1 atm	283	Bruker AVANCE III 750

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	800
2	Bruker	AVANCE III	750

NMR Refinement
Method	Details	Software
simulated annealing		Xplor-NIH

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	200
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	VNMR		Varian
5	collection	TopSpin		Bruker Biospin
6	data analysis	CcpNmr Analysis		CCPN
7	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
8	geometry optimization	TALOS		Cornilescu, Delaglio and Bax
9	structure calculation	CYANA		Guntert, Mumenthaler and Wuthrich
2	structure calculation	Xplor-NIH		Schwieters, Kuszewski, Tjandra and Clore
3	chemical shift assignment	CcpNmr Analysis		CCPN
4	peak picking	CcpNmr Analysis		CCPN

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.